course of screening for intermediates of izenamicins, we obtained five 16-memberedlactone compounds and examined the biosynthetic pathways of izenamicins B2 and B3 after lactone formation. In this paper we describe the isolation, characterization and bioconversion of lactone moieties.
In our studies of intermediates of izenamicins, we investigated the fermentation products of izenamicins-producing microorganism, which showed neutral lipophilic properties and UV280 nm absorptions associated with dienone system, to obtain precursors of izenamicins.
Micromonospora sp. YS-02930Kwas cultivated on a rotary shaker at 28°C for 9 days in 500-ml Erlenmeyer flasks, each containing 60 ml of medium consisting of 5%corn starch, 2%dry yeast, 0.2% FEB. 1994 MgSO4-7H2O, 0.15% CaCO3, and 0.001% CoCl2-6H2O. The broth filtrate (3 liters) was adjusted to pH 7 and extracted with equal volume of EtOAc. reported previously2), except for the assignment of C-3 and C-6 which were revised by interpretation of2D NMRspectra. The assignments of 13C NMR spectra were listed in Table 2 . 1 showed the same optical rotation as reported3) (-17.3°observed for 1; -15.4°as reported), which was chemically transformed from tylosin.
So, 1 was the same absolute stereochemistry as protylonolide. The molecular formula of 2 was deduced from MSand NMR,containing one additional oxygen in comparison with that of 1. The 13C NMR spectrum of 2 was quite similar to that of 1, except a oxymethine signal at 67.6ppm where methylene signal at 22.6ppm was observed in 1 ( Table 2 ). The structure of 2 was finally determined by an extensive 2D NMRexperiment as 1 9,23-dihydroxyprotylonolide.
The structures of3, 4, and 5 were also determined based on the comparison of *H and 13C NMR spectra (Table 2 ) with those of 1 and the extensive 2D NMRexperiments.
Amongthese 16-membered lactone compounds, 2, 3, and 4 are new compounds. 1 and 5 were previously obtained by microbial transformation from protylonolide2), and 1 was also obtained by chemical transformation from tylosin3). However, this was the first evidence that 1 and 5 were isolated from fermentation products.
All five compounds were inactive against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Micrococcus luteus, and Candida albicans at the concentration of 1 mg/ml by paper disc assay. From the point of biosynthesis, we proposed that 251 1 and 3 were precursors of izenamicins B3 (6) and B2 (7), respectively.
To examine biosynthetic pathways of 6 and 7, bioconversion experiments, using novel fatty acid synthesis inhibitor cerulenin4), were carried out.
Micromonospora sp. YS-02930K was cultured in a izenamicins production medium (5 % corn starch, 2% dry yeast, 0.1% amylase, 0.15% CaCO3, 0.002%
To the culture medium 40^g/ml of cerulenin was added initially and at a 24-hour interval to prevent the de novo synthesis of the lactone moieties. After 72 hours of cultivation, 50^g/ml of 1 was added and the cultivation was continued for further 86 hours, while monitoring izenamicins production by HPLC. As the result, 1 wasv converted to 6 in the yield 11%, so we concluded that 1 was an intermediate of 6. Bioconversion of 3 was carried out on the same condition mentioned above except 300^g/ml of 3 was added as the substrate. In this case, only a little amount of 3 was converted to 7, while much of 3 remained in the medium because of the poor production of7 by Micromonospora sp. YS-02930 K. Recently, rosamicin would be generated from rosamicin by oxidation at C-20 and successive decarbonylation5). Though there may exist a pathway where 7 is produced from 6 as is the case with rosamicin, our studies demonstrated another pathway that 19-decarbonyl skeleton was formed before glycosylation.
The results of the studies described here revealed the biosynthetic pathway of izenamicins and will be useful for the studies for production of izenamicin 
